Rimonabant: a guide to its use in obese and overweight patients

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 8, 2007-08 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Rimonabant, Gastrointestinal Motility and Obesity

By  

Current Neuropharmacology, Vol. 10, Iss. 3, 2012-09 ,pp. : 212-218

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study

By Florentin M   Liberopoulos EN   Filippatos TD   Kostara C   Tselepis A   Mikhailidis DP   Elisaf M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2741-2750

Informa Healthcare

Access to resources Recommend Favorite

Prevalence and Predictors of Overweight and Obesity in Patients with Pituitary Dysfunctions

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 4, 2017-02 ,pp. : 249-253

Bentham Science Publishers

Access to resources Recommend Favorite

Is rimonabant efficacious and safe in the treatment of obesity?

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2727-2731

Informa Healthcare

Access to resources Recommend Favorite